Browse by author
Lookup NU author(s): Professor Alan Boddy,
Professor Herbie Newell,
Professor Andrew Pearson
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Two patients with relapsed Wilms' tumour and renal failure requiring dialysis were given carboplatin and etoposide by pharmacokinetically guided dosing. The target area under the drug plasma concentration vs lime curve (AUC) was 6 mg ml-1 min for carboplatin and 18 and 21 mg ml-1 min for etoposide. On course 1 measured AUCs of carboplatin and etoposide were 6 and 20 mg ml-1 min for patient 1 and 6 and 21 mg ml-1 min for patient 2 respectively. Peritoneal dialysis did not remove carboplatin or etoposide from the plasma, however carboplatin but not etoposide was cleared by haemodialysis. Therapy with carboplatin and etoposide is possible in children and adults with renal failure who require dialysis, but in this situation pharmacokinetic monitoring is essential.
Author(s): English, M., Lowis, S., Peng, B., Boddy, A. V., Newell, D. R., Price, L., Pearson, A. D. J.
Publication type: Article
Publication status: Published
Journal: British Journal of Cancer
Print publication date: 01/03/1996
ISSN (print): 0007-0920
PubMed id: 8611379